1-((2,4-Dichlorophenethyl)Amino)3-Phenoxypropan-2-ol Kills Pseudomonas aeruginosa through Extensive Membrane Damage
| Autor: | Valerie Defraine, Veerle Liebens, Evelien Loos, Toon Swings, Bram Weytjens, Carolina Fierro, Kathleen Marchal, Liam Sharkey, Alex J. O’Neill, Romu Corbau, Arnaud Marchand, Patrick Chaltin, Maarten Fauvart, Jan Michiels |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Microbiology (medical) Multidrug tolerance Membrane permeability medicine.drug_class Antibiotic sensitivity 030106 microbiology Antibiotics lcsh:QR1-502 antibiotic tolerance LIPOPOLYSACCHARIDE medicine.disease_cause Microbiology lcsh:Microbiology 03 medical and health sciences Antibiotic resistance medicine MEXCD-OPRJ INTERACTION NETWORKS DRUG Original Research ANTIMICROBIAL RESISTANCE Pseudomonas aeruginosa Chemistry Biofilm Biology and Life Sciences BACTERIAL PERSISTER CELLS INFECTIONS membrane damage DISCOVERY mechanism of action studies ACID IBCN Efflux MULTIDRUG EFFLUX PUMPS ANTIBIOTIC SUSCEPTIBILITY anti-persister therapies |
| Zdroj: | Frontiers in Microbiology, Vol 9 (2018) FRONTIERS IN MICROBIOLOGY Frontiers in Microbiology |
| ISSN: | 1664-302X |
| Popis: | The ever increasing multidrug-resistance of clinically important pathogens and the lack of novel antibiotics have resulted in a true antibiotic crisis where many antibiotics are no longer effective. Further complicating the treatment of bacterial infections are antibiotic-tolerant persister cells. Besides being responsible for the recalcitrant nature of chronic infections, persister cells greatly contribute to the observed antibiotic tolerance in biofilms and even facilitate the emergence of antibiotic resistance. Evidently, eradication of these persister cells could greatly improve patient outcomes and targeting persistence may provide an alternative approach in combatting chronic infections. We recently characterized 1-((2,4-dichlorophenethyl)amino)-3-phenoxypropan-2-ol (SPI009), a novel anti-persister molecule capable of directly killing persisters from both Gram-negative and Gram-positive pathogens. SPI009 potentiates antibiotic activity in several in vitro and in vivo infection models and possesses promising anti-biofilm activity. Strikingly, SPI009 restores antibiotic sensitivity even in resistant strains. In this study, we investigated the mode of action of this novel compound using several parallel approaches. Genetic analyses and a macromolecular synthesis assays suggest that SPI009 acts by causing extensive membrane damage. This hypothesis was confirmed by liposome leakage assay and membrane permeability studies, demonstrating that SPI009 rapidly impairs the bacterial outer and inner membranes. Evaluation of SPI009-resistant mutants, which only could be generated under severe selection pressure, suggested a possible role for the MexCD-OprJ efflux pump. Overall, our results demonstrate the extensive membrane-damaging activity of SPI009 and confirm its clinical potential in the development of novel anti-persister therapies. ispartof: Frontiers in Microbiology vol:9 issue:FEB ispartof: location:Switzerland status: published |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|